US7125677B2
(en)
*
|
1995-11-13 |
2006-10-24 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US5972697A
(en)
*
|
1995-11-13 |
1999-10-26 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US6277566B1
(en)
*
|
1998-02-13 |
2001-08-21 |
Phillip A. Beachy |
Method for identifying a hedgehog-mediated phosphorylation state dependent transcription factor
|
US20080085515A1
(en)
*
|
2000-03-24 |
2008-04-10 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
|
US20070298423A1
(en)
*
|
2000-03-24 |
2007-12-27 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by specific amplification and detection of their nucleotide sequences on arrays
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US7640484B2
(en)
|
2001-12-28 |
2009-12-29 |
Netapp, Inc. |
Triple parity technique for enabling efficient recovery from triple failures in a storage array
|
EP2241636A1
(en)
*
|
2002-03-13 |
2010-10-20 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7364846B2
(en)
*
|
2002-10-11 |
2008-04-29 |
Molecular Devices Corporation |
Gene expression profiling from FFPE samples
|
US8008003B2
(en)
|
2002-11-15 |
2011-08-30 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004070062A2
(en)
*
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
AU2004248120B2
(en)
*
|
2003-05-28 |
2009-04-23 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
EP1654361B2
(en)
†
|
2003-07-25 |
2023-01-18 |
Life Technologies Corporation |
Methods and compositions for preparing rna from a fixed sample
|
DE10344799A1
(de)
*
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
FR2861744A1
(fr)
*
|
2003-11-05 |
2005-05-06 |
Biomerieux Sa |
Procede pour le pronostic du cancer du sein
|
CA2551267C
(en)
*
|
2003-12-23 |
2012-05-01 |
Genomic Health, Inc. |
Universal amplification of fragmented rna
|
EP1759010A4
(en)
*
|
2004-01-07 |
2008-12-24 |
Bristol Myers Squibb Co |
BIOMARKERS AND METHOD FOR DETERMINING SENSITIVITY AGAINST MODULATORS OF EGF (EPIDERMAL GROWTH FACTOR) RECEPTORS
|
US20050221398A1
(en)
*
|
2004-01-16 |
2005-10-06 |
Ipsogen, Sas, A Corporation Of France |
Protein expression profiling and breast cancer prognosis
|
WO2005087948A2
(en)
*
|
2004-03-12 |
2005-09-22 |
The Queen's University Of Belfast |
Cancer treatment and assays for determining resistance to platinum-based chemotherapeutic agent
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
EP2163650B1
(en)
*
|
2004-04-09 |
2015-08-05 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
WO2005118879A2
(en)
*
|
2004-06-04 |
2005-12-15 |
Arcturus Bioscience, Inc. |
Identification of tumors
|
US20120258442A1
(en)
*
|
2011-04-09 |
2012-10-11 |
bio Theranostics, Inc. |
Determining tumor origin
|
EP2272987A3
(en)
*
|
2004-07-09 |
2012-04-11 |
University of Pittsburgh of the Commonwealth System of Higher Education |
Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
|
DE102004042822A1
(de)
*
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
CA2586201A1
(en)
*
|
2004-11-03 |
2006-05-11 |
Almac Diagnostics Limited |
Transcriptome microarray technology and methods of using the same
|
DK1836629T3
(da)
*
|
2004-11-05 |
2020-05-18 |
Genomic Health Inc |
Forudsigelse af respons på kemoterapi ved anvendelse af markører for genekspression
|
AU2005304878B2
(en)
*
|
2004-11-05 |
2010-07-08 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
US8535914B2
(en)
*
|
2005-01-21 |
2013-09-17 |
Canon Kabushiki Kaisha |
Probe, probe set and information acquisition method using the same
|
WO2006101925A2
(en)
*
|
2005-03-16 |
2006-09-28 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
US8383357B2
(en)
|
2005-03-16 |
2013-02-26 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
EP1863930A2
(en)
*
|
2005-04-01 |
2007-12-12 |
NCC Technology Ventures Pte Limited |
Materials and methods relating to breast cancer classification
|
US8652786B2
(en)
|
2005-04-05 |
2014-02-18 |
The General Hospital Corporation |
Method for predicting responsiveness to drugs
|
US20060275844A1
(en)
*
|
2005-04-19 |
2006-12-07 |
Linke Steven P |
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
|
EP2365092A1
(en)
|
2005-06-03 |
2011-09-14 |
Aviaradx, Inc. |
Identification of tumors and tissues
|
WO2006135886A2
(en)
*
|
2005-06-13 |
2006-12-21 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US7700299B2
(en)
*
|
2005-08-12 |
2010-04-20 |
Hoffmann-La Roche Inc. |
Method for predicting the response to a treatment
|
CA2620195A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
CA2622050A1
(en)
*
|
2005-09-09 |
2007-03-15 |
The Board Of Regents Of The University Of Texas System |
A calculated index of genomic expression of estrogen receptor (er) and er related genes
|
EP1946114A4
(en)
*
|
2005-09-21 |
2010-05-26 |
Ccc Diagnostics Llc |
EXHAUSTIVE DIAGNOSTIC TEST PROCEDURES FOR PERSONALIZED ANTICANCER CHEMOTHERAPIES
|
EP1945754B1
(en)
|
2005-10-31 |
2014-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US20070128636A1
(en)
*
|
2005-12-05 |
2007-06-07 |
Baker Joffre B |
Predictors Of Patient Response To Treatment With EGFR Inhibitors
|
ES2536423T3
(es)
*
|
2006-01-05 |
2015-05-25 |
The Ohio State University Research Foundation |
Métodos basados en microARN para el diagnóstico de cáncer de próstata
|
US20100137163A1
(en)
|
2006-01-11 |
2010-06-03 |
Link Darren R |
Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
|
AU2007212278A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of South Florida |
Detection of cancer by elevated levels of Bcl-2
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
CN101240331A
(zh)
*
|
2006-04-07 |
2008-08-13 |
甄二真 |
基于mEPHX基因多态性的皮肤美容保健方法
|
US20070254305A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Nsabp Foundation, Inc. |
Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US20080003142A1
(en)
|
2006-05-11 |
2008-01-03 |
Link Darren R |
Microfluidic devices
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
EP3399450A1
(en)
|
2006-05-18 |
2018-11-07 |
Caris MPI, Inc. |
System and method for determining individualized medical intervention for a disease state
|
US8372584B2
(en)
|
2006-06-14 |
2013-02-12 |
The General Hospital Corporation |
Rare cell analysis using sample splitting and DNA tags
|
US20080050739A1
(en)
*
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
WO2007147074A2
(en)
|
2006-06-14 |
2007-12-21 |
Living Microsystems, Inc. |
Use of highly parallel snp genotyping for fetal diagnosis
|
WO2008008284A2
(en)
*
|
2006-07-14 |
2008-01-17 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use threof
|
US9012390B2
(en)
|
2006-08-07 |
2015-04-21 |
Raindance Technologies, Inc. |
Fluorocarbon emulsion stabilizing surfactants
|
US20080118576A1
(en)
*
|
2006-08-28 |
2008-05-22 |
Dan Theodorescu |
Prediction of an agent's or agents' activity across different cells and tissue types
|
EP2354254A1
(en)
*
|
2006-09-06 |
2011-08-10 |
Ortho-McNeil Pharmaceutical, Inc. |
Biomarkers for assessing response to C-met treatment
|
WO2008031041A2
(en)
*
|
2006-09-07 |
2008-03-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Melanoma gene signature
|
EP2081950B1
(en)
*
|
2006-09-21 |
2013-03-20 |
Nuclea Biomarkers LLC |
Expression profiles associated with irinotecan treatment
|
JP5041580B2
(ja)
*
|
2006-10-17 |
2012-10-03 |
一般財団法人化学及血清療法研究所 |
仲介ポリヌクレオチド
|
US20080125358A1
(en)
*
|
2006-10-26 |
2008-05-29 |
University Of Massachusetts Medical School |
Methods for Chk2 inhibitor patient selection
|
KR100862972B1
(ko)
|
2006-10-30 |
2008-10-13 |
한국과학기술연구원 |
휘발성 유기 화합물 검색용 바이오마커 및 이를 이용한유해성을 나타내는 휘발성 유기 화합물 검색 방법
|
WO2008063521A2
(en)
*
|
2006-11-13 |
2008-05-29 |
The General Hospital Corporation |
Gene-based clinical scoring system
|
KR100886670B1
(ko)
|
2007-01-11 |
2009-03-04 |
김현기 |
유두갑상선암의 새로운 진단마커 및 진단방법
|
US8148147B2
(en)
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
EP2134860A1
(en)
|
2007-04-13 |
2009-12-23 |
OSI Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to kinase inhibitors
|
KR20090128474A
(ko)
*
|
2007-04-13 |
2009-12-15 |
브리스톨-마이어스 스큅 컴퍼니 |
혈관 내피 성장인자 수용체-2 조절제에 대한 감수성을 판정하기 위한 방법 및 바이오마커
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
WO2008150937A2
(en)
*
|
2007-05-29 |
2008-12-11 |
Aivaradx, Inc. |
Real-time pcr
|
EP2167683A4
(en)
|
2007-05-31 |
2010-10-20 |
California Pacific Med Center |
METHOD FOR PREDICTING OR DIAGNOSING GASTROINTESTINAL DISORDER OR DISEASE
|
ES2583377T3
(es)
|
2007-06-08 |
2016-09-20 |
Genentech, Inc. |
Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
JP5480132B2
(ja)
|
2007-06-15 |
2014-04-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
Drosha媒介性のマイクロrnaプロセッシングを標的するための癌原性all−1融合タンパク質
|
US8883440B2
(en)
|
2007-07-26 |
2014-11-11 |
Nancy M. Lee |
Method to predict or diagnose a gastrointestinal disorder or disease
|
EP2650383A1
(en)
|
2007-08-03 |
2013-10-16 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncRNAs
|
EP2228457A1
(en)
*
|
2007-08-16 |
2010-09-15 |
Genomic Health, Inc. |
Gene expression markers of recurrence risk in cancer patients after chemotherapy
|
EP2028600B1
(en)
|
2007-08-24 |
2016-10-26 |
Sysmex Corporation |
Diagnosis support system for cancer, diagnosis support for information providing method for cancer, and computer program product
|
US9388457B2
(en)
*
|
2007-09-14 |
2016-07-12 |
Affymetrix, Inc. |
Locus specific amplification using array probes
|
JP2010538658A
(ja)
*
|
2007-09-14 |
2010-12-16 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
前立腺癌バイオマーカー
|
US8716190B2
(en)
|
2007-09-14 |
2014-05-06 |
Affymetrix, Inc. |
Amplification and analysis of selected targets on solid supports
|
US7939272B2
(en)
|
2007-10-03 |
2011-05-10 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
US8048621B2
(en)
|
2007-10-03 |
2011-11-01 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
US20100297639A1
(en)
*
|
2007-10-09 |
2010-11-25 |
University Of Washington Through Its Center For Commercialization |
Quantitative/semi-quantitative measurement of epor on cancer cells
|
US9873915B2
(en)
*
|
2007-10-16 |
2018-01-23 |
Ventana Medical Systems, Inc. |
Grading, staging and prognosing cancer using osteopontin-C
|
WO2009055559A1
(en)
*
|
2007-10-23 |
2009-04-30 |
University Of South Florida |
Method of predicting chemotherapeutic responsiveness of cancer
|
CN103898069A
(zh)
|
2007-10-26 |
2014-07-02 |
俄亥俄州立大学研究基金会 |
鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途
|
EP2065473A1
(en)
*
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic success in gynecologic cancer
|
US9932639B2
(en)
|
2007-11-30 |
2018-04-03 |
Ralph Markus Wirtz |
Method for predicting therapy responsiveness in basal like tumors
|
WO2009075799A2
(en)
*
|
2007-12-05 |
2009-06-18 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
EP2235536A4
(en)
|
2007-12-20 |
2011-05-04 |
Lab Corp America Holdings |
HER-2 DIAGNOSTIC METHODS
|
EP2607497B1
(en)
|
2008-05-12 |
2014-10-01 |
Genomic Health, Inc. |
Tests to predict responsiveness of cancer patients to chemotherapy treatment options
|
EP2288727B1
(en)
*
|
2008-05-14 |
2013-07-10 |
Genomic Health, Inc. |
Predictors of patient response to treatment with egf receptor inhibitors
|
US20110318732A1
(en)
*
|
2008-05-28 |
2011-12-29 |
Singer Robert H |
Prediction of chemotherapeutic response via single-cell profiling of transcription site activation
|
JP5745401B2
(ja)
|
2008-06-11 |
2015-07-08 |
アメリカ合衆国 |
肝細胞癌についての予測マーカーとしてのMiR−26ファミリーの使用および療法に対する反応性
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
EP2318552B1
(en)
|
2008-09-05 |
2016-11-23 |
TOMA Biosciences, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
US10359425B2
(en)
*
|
2008-09-09 |
2019-07-23 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
CA2737643C
(en)
|
2008-09-20 |
2020-10-06 |
Hei-Mun Fan |
Noninvasive diagnosis of fetal aneuploidy by sequencing
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
US20100221752A2
(en)
*
|
2008-10-06 |
2010-09-02 |
Somalogic, Inc. |
Ovarian Cancer Biomarkers and Uses Thereof
|
EP2347009A4
(en)
*
|
2008-10-14 |
2012-05-30 |
Caris Mpi Inc |
GENE AND GENE EXPRESSED TARGET PROTEINS FOR THE PRESENTATION OF BIOMARKERS AND SIGNATURES BY TUMOR TYPE
|
EP2722400A3
(en)
*
|
2008-10-29 |
2014-07-09 |
William Beaumont Hospital |
Methods of using biomarkers
|
CA2743211A1
(en)
|
2008-11-12 |
2010-05-20 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Methods and systems of using exosomes for determining phenotypes
|
EP2438442B1
(en)
|
2008-12-01 |
2017-08-09 |
Laboratory Corporation of America Holdings |
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
|
US20120041274A1
(en)
|
2010-01-07 |
2012-02-16 |
Myriad Genetics, Incorporated |
Cancer biomarkers
|
JP5746051B2
(ja)
|
2009-01-15 |
2015-07-08 |
ラボラトリー コーポレイション オブ アメリカ ホールディングス |
Her−3の測定による患者の反応を判定する方法
|
CN102439452B
(zh)
*
|
2009-01-15 |
2015-04-15 |
美国控股实验室公司 |
通过测量her-2表达确定患者应答的方法
|
WO2010099137A2
(en)
*
|
2009-02-26 |
2010-09-02 |
Osi Pharmaceuticals, Inc. |
In situ methods for monitoring the emt status of tumor cells in vivo
|
EP3415235A1
(en)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation of microfluidic droplets
|
EP2425021A4
(en)
*
|
2009-05-01 |
2013-03-06 |
Nuvera Biosciences Inc |
INDEX OF GENOMEXPRESSION OF ESTROGEN RECEPTOR (ER) AND ER-ASSOCIATED GENES
|
WO2010135411A2
(en)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Aurora-a copy number and sensitivity to inhibitors
|
EP2278026A1
(en)
*
|
2009-07-23 |
2011-01-26 |
Université de la Méditerranée |
A method for predicting clinical outcome of patients with breast carcinoma
|
EP3461912B1
(en)
|
2009-09-09 |
2022-07-13 |
The General Hospital Corporation |
Use of microvesicles in analyzing nucleic acid profiles
|
WO2011038063A1
(en)
|
2009-09-28 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Method of diagnosing and treating interstitial cystitis
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
US7736861B1
(en)
*
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
WO2011063274A2
(en)
*
|
2009-11-23 |
2011-05-26 |
Genomic Health, Inc. |
Methods to predict clinical outcome of cancer
|
AU2010321555B2
(en)
|
2009-11-23 |
2015-10-15 |
The Ohio State University |
Materials and methods useful for affecting tumor cell growth, migration and invasion
|
EP2507396A4
(en)
*
|
2009-12-01 |
2013-06-19 |
Precision Therapeutics Inc |
MULTI-MEDICATION RESPONSE MARKERS FOR BREAST CANCER CELLS
|
WO2011079176A2
(en)
|
2009-12-23 |
2011-06-30 |
Raindance Technologies, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
EP2524055A4
(en)
|
2010-01-11 |
2013-06-05 |
Genomic Health Inc |
METHOD FOR THE USE OF GENE EXPRESSION FOR DETERMINING THE PROBABILITY OF CLINICAL EXERCISE OF KIDNEY CANCER
|
US20130011393A1
(en)
*
|
2010-01-12 |
2013-01-10 |
Johnathan Mark Lancaster |
Bad pathway gene signature
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
WO2011100604A2
(en)
|
2010-02-12 |
2011-08-18 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9128101B2
(en)
|
2010-03-01 |
2015-09-08 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarkers for theranostics
|
US20130143753A1
(en)
*
|
2010-03-01 |
2013-06-06 |
Adelbio |
Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
|
WO2011109637A1
(en)
*
|
2010-03-03 |
2011-09-09 |
Koo Foundation Sun Yat-Sen Cancer Center |
Methods for classifying and treating breast cancers
|
WO2011109584A2
(en)
*
|
2010-03-03 |
2011-09-09 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
JP5553661B2
(ja)
|
2010-03-30 |
2014-07-16 |
シスメックス株式会社 |
癌の再発リスク判定方法
|
WO2011123446A1
(en)
|
2010-03-30 |
2011-10-06 |
Flatland Martin L |
Tissue excision device
|
WO2011122859A2
(ko)
*
|
2010-03-30 |
2011-10-06 |
서울대학교 산학협력단 |
뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
|
JP2013526852A
(ja)
|
2010-04-06 |
2013-06-27 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
疾患に対する循環バイオマーカー
|
US20120003639A1
(en)
*
|
2010-04-27 |
2012-01-05 |
Prelude, Inc. |
Cancer biomarkers and methods of use thereof
|
CA2800684A1
(en)
*
|
2010-05-26 |
2011-12-01 |
Expression Pathology, Inc. |
Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein selected reaction monitoring assay
|
CA2804391A1
(en)
|
2010-07-07 |
2012-01-12 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
CA2801110C
(en)
|
2010-07-09 |
2021-10-05 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
DE102010033575B4
(de)
|
2010-08-02 |
2016-01-14 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
ASPP2-Splicevariante
|
CA2804857C
(en)
|
2010-08-13 |
2021-07-06 |
Somalogic, Inc. |
Pancreatic cancer biomarkers and uses thereof
|
US9605319B2
(en)
|
2010-08-30 |
2017-03-28 |
Myriad Genetics, Inc. |
Gene signatures for cancer diagnosis and prognosis
|
EP3447155A1
(en)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
EP2637673B1
(en)
|
2010-11-12 |
2016-10-26 |
The Ohio State University Research Foundation |
Methods related to microrna-21 and mismatch repair in colorectal cancer
|
US10758619B2
(en)
|
2010-11-15 |
2020-09-01 |
The Ohio State University |
Controlled release mucoadhesive systems
|
WO2012090073A2
(en)
*
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
WO2012097368A2
(en)
*
|
2011-01-14 |
2012-07-19 |
Response Genetics, Inc. |
Her3 and her4 primers and probes for detecting her3 and her4 mrna expression
|
WO2012109233A2
(en)
*
|
2011-02-07 |
2012-08-16 |
Board Of Regents, The University Of Texas System |
Methods for predicting recurrence risk in breast cancer patients
|
US9364803B2
(en)
|
2011-02-11 |
2016-06-14 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
WO2012122239A1
(en)
|
2011-03-07 |
2012-09-13 |
The Ohio State University |
MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
|
EP2702173A1
(en)
|
2011-04-25 |
2014-03-05 |
OSI Pharmaceuticals, LLC |
Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
WO2012167142A2
(en)
|
2011-06-02 |
2012-12-06 |
Raindance Technolgies, Inc. |
Enzyme quantification
|
EP2726609A4
(en)
*
|
2011-07-01 |
2015-03-04 |
Pinpoint Genomics Inc |
PROCESS FOR EXTRACTING RNA FROM FIXED, COATED TISSUE
|
EP2744916A4
(en)
|
2011-07-13 |
2015-06-17 |
Primeradx Inc |
MULTIMODAL METHODS FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF MULTIPLE NUCLEIC ACIDS IN A SAMPLE
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
GB201114919D0
(en)
*
|
2011-08-30 |
2011-10-12 |
Glaxosmithkline Biolog Sa |
Method
|
CN102533740B
(zh)
*
|
2011-09-07 |
2013-07-24 |
杭州艾迪康医学检验中心有限公司 |
人白血病融合基因bcr-abl的rt-pcr引物及其使用方法
|
JP2014530612A
(ja)
|
2011-10-14 |
2014-11-20 |
ジ・オハイオ・ステート・ユニバーシティ |
卵巣がんに関する方法および材料
|
AU2012336120B2
(en)
*
|
2011-11-08 |
2017-10-26 |
Genomic Health, Inc. |
Method of predicting breast cancer prognosis
|
CN103145845A
(zh)
*
|
2011-12-06 |
2013-06-12 |
吉林圣元科技有限责任公司 |
Tat与人野生型P53融合蛋白在毕赤酵母中的表达
|
AU2012352265B2
(en)
|
2011-12-13 |
2017-02-16 |
Ohio State Innovation Foundation |
Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
|
EP2804960A4
(en)
|
2012-01-20 |
2015-08-19 |
Univ Ohio State |
BREAST CANCER BIOMARK SIGNATURES FOR INVASIVITY AND FORECAST
|
EP3495817A1
(en)
|
2012-02-10 |
2019-06-12 |
Raindance Technologies, Inc. |
Molecular diagnostic screening assay
|
WO2013165748A1
(en)
|
2012-04-30 |
2013-11-07 |
Raindance Technologies, Inc |
Digital analyte analysis
|
BR112014032728A2
(pt)
|
2012-06-27 |
2017-11-28 |
Berg Llc |
uso de marcadores no diagnóstico e tratamento de câncer de próstata
|
WO2014078700A1
(en)
|
2012-11-16 |
2014-05-22 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
US20140186468A1
(en)
*
|
2012-12-07 |
2014-07-03 |
Susana Gonzalo |
Diagnosing subsets of triple-negative breast cancer
|
KR20150107738A
(ko)
|
2013-01-18 |
2015-09-23 |
엘리스 클라인 |
암의 면역 프로그래밍 및 치료를 위한 선택적 글라이코시다제 섭생
|
CN104981697B
(zh)
|
2013-02-11 |
2017-08-04 |
英丘伦有限责任公司 |
促染色质转录复合物(fact)在癌症中的用途
|
EP2986762B1
(en)
|
2013-04-19 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
CA2912786A1
(en)
*
|
2013-05-21 |
2014-11-27 |
Dignity Health |
Genetic signature of vulnerability to inhibitors of base excision repair (ber) in cancer
|
JP2016521979A
(ja)
|
2013-05-30 |
2016-07-28 |
ジェノミック ヘルス, インコーポレイテッド |
腎臓がんを有する患者に対する再発スコアを計算するための遺伝子発現プロファイルアルゴリズム
|
WO2015048098A1
(en)
|
2013-09-24 |
2015-04-02 |
Washington University |
Diagnostic methods for infectious disease using endogenous gene expression
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
CA2947624A1
(en)
|
2014-05-13 |
2015-11-19 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
WO2015187612A1
(en)
|
2014-06-02 |
2015-12-10 |
Valley Health System |
Method and systems for lung cancer diagnosis
|
US9994912B2
(en)
|
2014-07-03 |
2018-06-12 |
Abbott Molecular Inc. |
Materials and methods for assessing progression of prostate cancer
|
EP3517954A1
(en)
*
|
2014-10-17 |
2019-07-31 |
Assistance Publique - Hôpitaux de Paris |
Methods for the monitoring and prognosis of a bladder cancer
|
DK3210142T3
(da)
|
2014-10-24 |
2020-11-16 |
Koninklijke Philips Nv |
Vurdering af tgf-cellulær signaleringsvejaktivitet under anvendelse af matematisk modellering af målgenekspression
|
JP7065609B6
(ja)
|
2014-10-24 |
2022-06-06 |
コーニンクレッカ フィリップス エヌ ヴェ |
複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測
|
US11610644B2
(en)
|
2014-10-24 |
2023-03-21 |
Koninklijke Philips N.V. |
Superior bioinformatics process for identifying at risk subject populations
|
WO2016090323A1
(en)
|
2014-12-05 |
2016-06-09 |
Prelude, Inc. |
Dcis recurrence and invasive breast cancer
|
SG10202012249YA
(en)
|
2014-12-08 |
2021-01-28 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
US20180228740A1
(en)
|
2015-08-06 |
2018-08-16 |
The Wistar Institute Of Anatomy And Biology |
Combination therapies targeting mitochondrial biogenesis for cancer therapy
|
ES2861400T3
(es)
|
2015-08-14 |
2021-10-06 |
Koninklijke Philips Nv |
Evaluación de la actividad de la ruta de señalización celular de NFkB usando modelos matemáticos de la expresión de genes diana
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
BR112018076528A2
(pt)
|
2016-06-21 |
2019-04-02 |
The Wistar Institute Of Anatomy And Biology |
composições e métodos para diagnosticar cânceres de pulmão usando perfis de expressão gênica
|
US10487365B2
(en)
|
2016-09-20 |
2019-11-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for detecting expression of lnc-FANCI-2 in cervical cells
|
US11229662B2
(en)
|
2016-11-15 |
2022-01-25 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
KR101950717B1
(ko)
*
|
2016-11-23 |
2019-02-21 |
주식회사 젠큐릭스 |
유방암 환자의 화학치료 유용성 예측 방법
|
US10636512B2
(en)
|
2017-07-14 |
2020-04-28 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
US10998178B2
(en)
|
2017-08-28 |
2021-05-04 |
Purdue Research Foundation |
Systems and methods for sample analysis using swabs
|
EP3461915A1
(en)
|
2017-10-02 |
2019-04-03 |
Koninklijke Philips N.V. |
Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
|
CA3082643A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
EP3502279A1
(en)
|
2017-12-20 |
2019-06-26 |
Koninklijke Philips N.V. |
Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
|
CN110045120A
(zh)
*
|
2018-01-15 |
2019-07-23 |
长庚医疗财团法人基隆长庚纪念医院 |
检测生物样品中wisp1的浓度在制备用于乳癌筛检及侦测复发的检测试剂盒及其应用
|
WO2020056162A1
(en)
*
|
2018-09-12 |
2020-03-19 |
Oregon Health & Science University |
Detecting and/or subtyping circulating hybrid cells that correlate with stage and survival
|
CA3112792A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
WO2020178399A1
(en)
|
2019-03-05 |
2020-09-10 |
Norwegian University Of Science And Technology (Ntnu) |
Breast cancer signature genes
|
US20230070840A1
(en)
*
|
2020-01-30 |
2023-03-09 |
Arocell Ab |
Predicting patient survival
|
AU2022262752A1
(en)
*
|
2021-04-21 |
2023-08-24 |
Apollomics Inc. |
Diagnostic and treatment of cancer using c-met inhibitor
|
EP4253567A1
(en)
*
|
2022-03-31 |
2023-10-04 |
OncoAssure Limited |
A method of predicting risk of an aggressive or recurrent cancer
|